| __timestamp | AstraZeneca PLC | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 79838000 |
| Thursday, January 1, 2015 | 5997000000 | 121816000 |
| Friday, January 1, 2016 | 5890000000 | 117633000 |
| Sunday, January 1, 2017 | 5757000000 | 117456000 |
| Monday, January 1, 2018 | 5932000000 | 171984000 |
| Tuesday, January 1, 2019 | 5958000000 | 257452000 |
| Wednesday, January 1, 2020 | 5991000000 | 477643000 |
| Friday, January 1, 2021 | 9736000000 | 540684000 |
| Saturday, January 1, 2022 | 9762000000 | 651496000 |
| Sunday, January 1, 2023 | 10935000000 | 666563000 |
| Monday, January 1, 2024 | 13583000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, AstraZeneca PLC and PTC Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. AstraZeneca, a global leader, has consistently increased its R&D budget, peaking at approximately $10.9 billion in 2023, a remarkable 96% increase from 2014. This surge underscores AstraZeneca's commitment to pioneering new treatments and maintaining its market dominance.
Conversely, PTC Therapeutics, a smaller biotech firm, has shown a steady yet modest increase in R&D spending, reaching around $667 million in 2023. This represents an impressive 735% growth since 2014, highlighting PTC's aggressive push to expand its therapeutic pipeline. These trends reflect the broader industry dynamics where established giants and nimble innovators are both crucial to advancing medical breakthroughs.
Research and Development: Comparing Key Metrics for AbbVie Inc. and AstraZeneca PLC
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Amgen Inc.
Comparing Innovation Spending: AstraZeneca PLC and Dr. Reddy's Laboratories Limited
R&D Spending Showdown: AstraZeneca PLC vs Pharming Group N.V.
AstraZeneca PLC vs Ionis Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: AstraZeneca PLC vs Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Bausch Health Companies Inc.
PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
PTC Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending